Personalized treatment planning for colorectal cancer surgery
Part of Cancer, Digestive system clinical trials.
This study focuses on tailoring (customizing) treatment plans for people with colorectal cancer who are scheduled for curative surgery. It may help doctors choose the most appropriate treatment approach after surgery using standard follow-up information.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have confirmed colorectal cancer based on a pathology report (tissue biopsy).
- Your cancer treatment plan includes curative surgery (aimed at removing the cancer).
- You will follow the study’s standard follow-up schedule after surgery.
- You are able and willing to sign the informed consent form.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at tissue samples from people with colorectal cancer to better understand tumor features and how they may respond to treatment. If you have colorectal cancer, the trial may help researchers match future treatments more effectively.
This study tests whether growing a patient's tumor cells in a dish (called an organoid) can help doctors choose the best next treatment. It is for people with advanced colorectal or pancreatic cancer who have run out of standard options.
This trial uses advanced testing (genetic sequencing and lab-grown tumor models) to find the best treatment for people with advanced solid tumors that haven't responded to at least one standard treatment. The goal is to personalize therapy based on your tumor's unique features.
This Phase 2 study tests the best way to choose and then follow treatment when colorectal cancer has spread only to a small number of spots. You may be eligible if your doctors can remove or precisely treat the spots and there’s no sign of additional spread on scans.
This trial studies personalized (precision) treatment decisions for people with advanced or recurrent colorectal cancer. It aims to improve outcomes while carefully monitoring safety and how well the plan fits each participant.
This study tests if matching treatments to your tumor's genetic markers can help slow down metastatic colorectal cancer. You'll get a biopsy and blood draw to guide your therapy.
Hear when a new Colorectal Neoplasms trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.